Nasdaq: CFRX
Navigate ContraFect Corporation
Home
About Us
Overview
Management Team
Board of Directors
Technology
Overview
Lysins
Amurins
Publications / Posters
Video Library
Pipeline
Overview
Exebacase
CF-370
Gram-negative Lysins
Amurins
Investors & Media
Overview
News / Events
Presentations
Company Information
Financial Information
Analyst Coverage
Stock Data
SEC Filings
Corporate Governance
Careers
Contact Us
SEC Filings
Investors & Media
Home
Investors & Media
SEC Filings
Filter Filings:
View All
10-K
10-Q
10-Q/A
25
25-NSE
3
3/A
4
4/A
424B1
424B3
424B5
5
8-A12B
8-K
CERTNAS
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
02/14/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
14
02/14/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/12/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
11
02/11/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
02/04/20
8-K
Current report filing
Related Documents
EX-3.1
5
01/10/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
12
01/06/20
DEF 14A
Definitive proxy statements
25
12/27/19
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
25
12/19/19
8-K
Current report filing
Related Documents
EX-1.1
EX-5.1
44
12/18/19
424B5
Prospectus filed pursuant to Rule 424(b)(5)
60
<< Previous
1...
8
9
10
11
12
13
14
15
16
17
...51
Next >>